An interview with Dr Matt SilverJumping genes: a marker for early cancer analysis? An interview with Dr KazazianNovartis announces FDA authorization of Odomzo 200 mg capsules for treatment of laBCC patientsTwenty-five patients with newly diagnosed, very clear cell mRCC were enrolled in the scholarly study, of which 22 received at least one dosage of AGS-003. Following nephrectomy, patients initiated standard sunitinib therapy . After at least one sunitinib cycle, patients after that received concomitant AGS-003 injections every three weeks for to five doses up, and every three months until disease progression or end of study thereafter. Jeff Abbey, president and chief executive officer of Argos, added, ‘AGS-003 possesses all the tumor antigens, including the patient’s unique mutated antigens, in order to produce the broadest feasible immune response, limit tumor get away, and induce immunologic memory relevant to each patient.This can help prevent accidental injuries and insect bites. Wear insect repellent when you’re outdoors, in the evening especially. Of course, every kid gets a few scrapes and bug bites. When this happens to you, take these steps: Wash the cut or bite right away with soap and warm water, and wash it once a day time until it scabs over. Tell your parent so a grown-up can choose the best way to treat it. That might mean applying antibiotic ointment and a bandage, or for more serious cuts, going to see a doctor.. Altheos to invest in development of ATS907 Rho-kinase inhibitor with completed $20M Series A financing Altheos, Inc., a privately held early-stage biopharmaceutical business, announced today that it offers completed a $20 million Series A financing led by Bay City Capital.